Search
01/01/2023
Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients
Gironell A., Pascual-Sedano B., Marín-Lahoz J., Pérez J., Pagonabarraga J.. Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients. Movement Disorders Clinical Practice. 2023; 10(1)DOI:10.1002/mdc3.13576. PMID:36704076. IF:2.600(Q2/5D).
01/01/2023
Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders
Gonzalez-Herrero, B, Morgante, F, Pagonabarraga, J, Stanton, B, Edwards, MJ. Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders. Journal of Clinical Medicine. 2023; 12(1)DOI:10.3390/jcm12010299. PMID:36615098. IF:3.000(Q1/2D).
01/01/2023
Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease
Gil-Polo, C, Martinez-Horta, SI, Santalo, FS, Martin-Palencia, M, Gundin-Menendez, S, Alvarez-Banos, P, Maza-Pereg, L, Calvo, S, Collazo, C, Alonso-Garcia, E, Rinones-Mena, E, Arrabal-Alonso, A, Rodriguez, JN, Saiz-Rodriguez, M, Aguado, L, Mariscal, N, Munoz-Siscart, I, Pineiro, D, Rivadeneyra, J, Diez-Fairen, M, Miguel-Perez, I, Cubo, E. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease. Movement Disorders Clinical Practice. 2023; 10(2)DOI:10.1002/mdc3.13613. PMID:36825059. IF:2.600(Q2/5D).
01/01/2023
Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease
Sampedro F., Puig-Davi A., Martinez-Horta S., Pagonabarraga J., Horta-Barba A., Aracil-Bolaños I., Kulisevsky J.. Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 224DOI:10.1016/j.clineuro.2022.107531. PMID:36455303. IF:1.800(Q2/5D).
01/01/2023
Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness
Santos-García D., Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesús S., Buongiorno M.T., Planellas L., Cosgaya M., Caldentey, JG, Caballol N., Legarda I., Vara, JH, Cabo I., Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira V., Puente V., Garcia-Soto, JD, Borrué C., Vila, BS, Sauco, MA, Vela L., Escalante S., Cubo E., Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón I., Kulisevsky J., Gonzalez, MM, Seijo M., Martinez, JR, Valero C., Kurtis M., Ardura, JG, Redondo, RA, Ordás C., Diaz, LML, McAfee D., Martinez-Martin P., Mir P.. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness. Journal of Parkinsons Disease. 2023; 13(2)DOI:10.3233/JPD-225014. PMID:36683517. IF:4.000(Q2/3D).
01/01/2023
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease
Martínez M., Ariz M., Alvarez I., Castellanos G., Aguilar M., Hernández-Vara J., Caballol N., Garrido A., Bayés À., Vilas D., Marti M.J., Pascual-Sedano B., Marin J., Avila A., Buongiorno M., Tartari J.P., Puente V., Ezquerra M., Valldeoriola F., Compta Y., Tolosa E., Pont C., Pastor P., de Solórzano C.O., Pastor M.A.. Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease. npj Parkinsons Disease. 2023; 9(1)DOI:10.1038/s41531-023-00503-2. PMID:37061532. IF:6.700(Q1/1D).
01/01/2023
Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls
Butjosa, A, Usall, J, Vila-Badia, R, Mezquida, G, Cuesta, MJ, Rodriguez-Toscano, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Espliego, A, Corripio, I, Vieta, E, Baeza, I, Berge, D, Bernardo, M. Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. 2023; 69(1)DOI:10.1177/00207640211070398. PMID:35068217. IF:2.500(Q2/5D).
01/01/2023
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode
Segura, AG, Mezquida, G, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Moreno-Izco, L, Amoretti, S, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan-Bejarano, A, Vieta, E, de la Serna, E, Toll, A, Cuesta, MJ, Mas, S, Bernardo, M. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10)DOI:10.1017/S0033291722001544. PMID:35678455. IF:5.900(Q1/1D).